Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Groenier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Prostate Cancer and Prostatic Diseases|December 24, 2002
Ultrasound-guided seminal vesicle biopsies in prostate cancerL F A Wymenga, F J Duisterwinkel, K Groenier, et al.
BJU International|August 8, 2001
Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphataseL F Wymenga, J H Boomsma, K Groenier, et al.
The Canadian Journal of Urology|December 18, 2000
Reliability analysis of first and second generation PSA assaysL F Wymenga, K Groenier, P Visser-van Brummen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 1, 1996
The validity and reliability of the Diabetes Health Profile (DHP) in NIDDM patients referred for insulin therapyP Goddijn, H Bilo, K Meadows, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Complications and side effects: a problem in general practice?M Conradi, K Groenier, J Hutten, et al.
Journal of Manipulative and Physiological Therapeutics|May 1, 1997
Physical examination of the cervical spine and shoulder girdle in patients with shoulder complaintsJ S Sobel, J C Winters, K Groenier, et al.
BJU International|August 8, 2001
Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasisL F Wymenga, K Groenier, J Schuurman, et al.
Scandinavian Journal of Urology and Nephrology|August 29, 2000
Clinical implications of free-to-total immunoreactive prostate-specific antigen ratiosL F Wymenga, F J Duisterwinkel, K Groenier, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Prostate Cancer and Prostatic Diseases|December 24, 2002
Ultrasound-guided seminal vesicle biopsies in prostate cancerL F A Wymenga, F J Duisterwinkel, K Groenier, et al.
BJU International|August 8, 2001
Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphataseL F Wymenga, J H Boomsma, K Groenier, et al.
The Canadian Journal of Urology|December 18, 2000
Reliability analysis of first and second generation PSA assaysL F Wymenga, K Groenier, P Visser-van Brummen, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 1, 1996
The validity and reliability of the Diabetes Health Profile (DHP) in NIDDM patients referred for insulin therapyP Goddijn, H Bilo, K Meadows, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Complications and side effects: a problem in general practice?M Conradi, K Groenier, J Hutten, et al.
Journal of Manipulative and Physiological Therapeutics|May 1, 1997
Physical examination of the cervical spine and shoulder girdle in patients with shoulder complaintsJ S Sobel, J C Winters, K Groenier, et al.
BJU International|August 8, 2001
Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasisL F Wymenga, K Groenier, J Schuurman, et al.
Scandinavian Journal of Urology and Nephrology|August 29, 2000
Clinical implications of free-to-total immunoreactive prostate-specific antigen ratiosL F Wymenga, F J Duisterwinkel, K Groenier, et al.
Pageof 1